This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Cardiac Biomarker in Pediatric Heart Disease

This study has been completed.
Information provided by (Responsible Party):
Tomoyuki Kanazawa, Okayama University Identifier:
First received: April 15, 2013
Last updated: December 27, 2015
Last verified: December 2015
The purpose of this study is to investigate cardiac biomarker during perioperative management in pediatric cardiac surgery.

Congenital Heart Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of Cardiac Biomarker During Perioperative Management in Pediatric Heart Disease

Resource links provided by NLM:

Further study details as provided by Tomoyuki Kanazawa, Okayama University:

Primary Outcome Measures:
  • serious adverse events [ Time Frame: one month ]

Biospecimen Retention:   Samples With DNA

Enrollment: 74
Study Start Date: November 2012
Study Completion Date: December 2014
Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
pediatric patients who receive surgery for congenital heart disease under 18 years old

Inclusion Criteria:

  • children who receive surgery for congenital heart disease
  • require cardiopulmonary bypass for surgery
  • under 18 years old

Exclusion Criteria:

  • simple congenital heart disease (atrial septal defect, ventricle septal defect, patent ductus arteriosus)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01834976

Okayama University Hospital
Okayama, Japan, 7008558
Sponsors and Collaborators
Okayama University
  More Information

Responsible Party: Tomoyuki Kanazawa, Pediatric cardiac surgery investigators, Okayama University Identifier: NCT01834976     History of Changes
Other Study ID Numbers: pchd biomarker in okayama
Study First Received: April 15, 2013
Last Updated: December 27, 2015

Keywords provided by Tomoyuki Kanazawa, Okayama University:
cardiac biomarker
congenital heart disease

Additional relevant MeSH terms:
Heart Diseases
Heart Defects, Congenital
Cardiovascular Diseases
Cardiovascular Abnormalities
Congenital Abnormalities processed this record on August 16, 2017